|
Bayer AG v. Housey Pharm., Inc.
The CAFC affirmed the dismissal of Housey's infringement claims because it
concluded that infringement under section 271(g) of 35 U.S.C. is limited to
physical goods that were manufactured and does not include information
generated by a patented process, and because the physical goods here (drug
products) were not manufactured by a process claimed in the asserted
patents.
For more patent information, see
http://www.patentcribsheet.com/Cases/housey.html.
--------------------------------
This posting contains educational information for lawyers directly
impacting patent preparation and prosecution. It does not constitute legal
advice, nor does it create or constitute any attorney-client relationship.
|
| |
| |
|
